Virology News and Research

Latest Virology News and Research

AIDS Healthcare Foundation to hold free rapid HIV testing to mark World AIDS Day

In observation of World AIDS Day this year, AIDS Healthcare Foundation (AHF), the largest global AIDS group and which currently provides more than 15,000 free HIV and STD tests annually in California via its community-based testing programs, is hosting an extended day—and evening—of free rapid HIV testing this Saturday, November 28th, starting at 10 am, going until 2 am Sunday at its ‘Out of the Closet’ Hollywood thrift store and testing location (6210 Sunset). The HIV testing marathon is being held as part of AHF’s ‘Testing Millions’ campaign, a worldwide initiative to test more than three million people in conjunction with the observance of this year’s World AIDS Day, Tuesday, December 1st. In an effort to raise awareness about the event and HIV testing, LA’s KIIS radio station (102.7 FM) will have its mobile van broadcasting live from the testing event from 8 pm to 10 pm Saturday.

28 Nov 2009

Agriflu approved to prevent diseases caused by influenza virus subtypes A and B

The U.S. Food and Drug Administration today approved Agriflu for people ages 18 years and older to prevent disease caused by influenza virus subtypes A and B.

27 Nov 2009

Rights Issue to be carried out by keeping the authorization by the Annual General Meeting, resolves Tripep

The Board of Directors of Tripep AB (publhas on the 27th of November 2009, based on the authorization by the Annual General Meeting resolved to carry out a rights issue.

27 Nov 2009

Tripep completes clinical trial of ChronVac-C for Hepatitis C virus treatment

All samples from the 12 patients with chronic Hepatitis C genotype 1 treated with Tripep’s therapeutic vaccine ChronVac-C have now been collected. The treatment was found to be safe, immunogenic and had transient effects on the serum levels of hepatitis C virus.

27 Nov 2009

B cells and their antibodies defend against microbes and control commensal microflora

Microbes populated the earth long before any eukariotic cell. Therefore, in order to survive, mono and multi-cellular organisms had to develop mechanisms of adaptation, cohabitation and defense against bacteria, fungi and viruses. One of these mechanisms is mediated by immunoglobulins in the serum and at mucosal surfaces.

27 Nov 2009

Whitehead researchers develop new type of genetic screen for human cells

Whitehead researchers have developed a new type of genetic screen for human cells to pinpoint specific genes and proteins used by pathogens, according to their paper in Science.

27 Nov 2009

Experts say vitamin D assists body's immune system to fight against H1N1

The world's leading vitamin D experts say that raising your levels of "the sunshine vitamin" this winter might be the best way to help your body naturally raise its resistance to all forms of the flu virus - including the H1N1 swine flu virus.

26 Nov 2009

MUHC's innovative treatment for HIV patients passes first clinical trial successfully

An innovative treatment for HIV patients developed by McGill University Health Centre researchers has passed its first clinical trial with flying colours. The new approach is an immunotherapy customized for each individual patient, and was developed by Dr. J-P. Routy from the Research Institute of the MUHC in collaboration with Dr. R. S-kaly from the Universit- de Montr-al.

26 Nov 2009

Merck, Idera Pharmaceuticals extend their vaccine research collaboration

Idera Pharmaceuticals, Inc. today announced that Merck & Co., Inc., through an affiliate, has extended its research collaboration with Idera for a fourth year. In December 2006, the companies entered into an exclusive license and research collaboration agreement to research, develop, and commercialize vaccine products containing the Company’s investigational agonist compounds targeting Toll-like Receptors (TLRs) 7, 8, and 9 in the fields of oncology, infectious diseases, and Alzheimer’s disease.

26 Nov 2009

Free, confidential HIV testing at Northern California ‘Out of the Closet’ locations

To commemorate World AIDS Day 2009, AIDS Healthcare Foundation (AHF), together with local partners, will offer free, confidential HIV testing at all five of its popular Bay Area “Out of the Closet” Thrift Stores on Tuesday, December 1st, from 12:00 noon to 7:00 p.m. The events are part of AHF’s World AIDS Day 2009 “Testing Millions” campaign which seeks to test several million people for HIV in conjunction with this year’s observance of World AIDS Day.

26 Nov 2009

Some HIV patients experience improved quality of life post diagnosis, says new study

A new study from researchers at the University of Cincinnati (UC) and the Cincinnati Department of Veterans Affairs Medical Center reaffirms that some patients with HIV experience an improved quality of life following their diagnosis.

26 Nov 2009

Cells protect themselves against viruses and bacteria with novel non-genetic mechanism

When cells are confronted with an invading virus or bacteria or exposed to an irritating chemical, they protect themselves by going off their DNA recipe and inserting the wrong amino acid into new proteins to defend them against damage, scientists have discovered.

26 Nov 2009

Potentially dangerous needlestick injuries often go unreported

Medical students are commonly stuck by needles - putting them at risk of contracting potentially dangerous blood-borne diseases - and many of them fail to report the injuries to hospital authorities, according to a Johns Hopkins study published in the December issue of the journal Academic Medicine.

26 Nov 2009

Tibotec Therapeutics' INTELENCE granted FDA traditional approval

The FDA granted traditional approval for INTELENCE® (etravirine) tablets, a non-nucleoside reverse transcriptase inhibitor (NNRTI). INTELENCE is the only NNRTI specifically indicated for use in treatment-experienced adults who are experiencing virologic failure with HIV-1 strains resistant to an NNRTI and other antiretroviral (ARV) agents.

25 Nov 2009

Lethality of H1N1 virus has dropped from its peak of 3.7, shows new data

Biotech firm Replikins Ltd., which has analyzed the H1N1 virus' genomic data from the 1918 pandemic through the prediction, outbreak, and progress of the current H1N1 pandemic, today issued its latest biochemical analysis of the virus.

25 Nov 2009

WHO investigates cases of H1N1 drug resistance in U.S., Britain

The WHO is looking into reports that patients with "severely suppressed immune systems" in Britain and the U.S. developed resistance Tamiflu, which is used to treat the symptoms of H1N1 (swine flu), a spokesman for the organization said Tuesday, Reuters reports.

25 Nov 2009

Novartis to terminate its research collaboration agreement with Idera Pharmaceuticals

Idera Pharmaceuticals, Inc., today announced that Novartis will terminate its research collaboration agreement with the Company, effective as of February 21, 2010.

25 Nov 2009

Human Genome Sciences submits BLA for ZALBIN

Human Genome Sciences, Inc. today announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ZALBIN™ (albinterferon alfa-2b) for the treatment of chronic hepatitis C. The BLA submission includes the results of two pivotal Phase 3 clinical trials showing that 900-mcg albinterferon alfa-2b dosed every two weeks met its primary endpoint of non-inferiority to peginterferon alfa-2a (Pegasys) dosed once each week.

25 Nov 2009

FDA provides marketing clearance for Prodesse's ProParaflu+ assay

Gen-Probe Incorporated announced today that the US Food and Drug Administration (FDA) has cleared for marketing Prodesse's ProParaflu+(TM) assay, a molecular test that detects and differentiates parainfluenza 1, 2 and 3 viruses, which cause lower respiratory tract infections.

25 Nov 2009

Pharmaceutical research and biotechnology companies test medicines and vaccines to treat HIV/AIDS

America's pharmaceutical research and biotechnology companies are testing 97 medicines and vaccines to treat or prevent HIV/AIDS and related conditions, according to a new report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA).

25 Nov 2009

Virology News and Research

Latest Virology News and Research

AIDS Healthcare Foundation to hold free rapid HIV testing to mark World AIDS Day

Agriflu approved to prevent diseases caused by influenza virus subtypes A and B

Rights Issue to be carried out by keeping the authorization by the Annual General Meeting, resolves Tripep

Tripep completes clinical trial of ChronVac-C for Hepatitis C virus treatment

B cells and their antibodies defend against microbes and control commensal microflora

Whitehead researchers develop new type of genetic screen for human cells

Experts say vitamin D assists body's immune system to fight against H1N1

MUHC's innovative treatment for HIV patients passes first clinical trial successfully

Merck, Idera Pharmaceuticals extend their vaccine research collaboration

Free, confidential HIV testing at Northern California ‘Out of the Closet’ locations

Some HIV patients experience improved quality of life post diagnosis, says new study

Cells protect themselves against viruses and bacteria with novel non-genetic mechanism

Potentially dangerous needlestick injuries often go unreported

Tibotec Therapeutics' INTELENCE granted FDA traditional approval

Lethality of H1N1 virus has dropped from its peak of 3.7, shows new data

WHO investigates cases of H1N1 drug resistance in U.S., Britain

Novartis to terminate its research collaboration agreement with Idera Pharmaceuticals

Human Genome Sciences submits BLA for ZALBIN

FDA provides marketing clearance for Prodesse's ProParaflu+ assay

Pharmaceutical research and biotechnology companies test medicines and vaccines to treat HIV/AIDS

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production